COMPASS Pathways stock has delivered a very strong 1 year return, yet its current valuation checks and market multiples point ...
Compass Pathways plc upgraded to Strong Buy after phase 3 COMP360 TRD data & fast-track FDA NDA review; see catalysts, ...
Clinical Trials Arena on MSN
Compass’ psilocybin shows six-month durability in Phase III trial
Compass has already submitted for approval of its psilocybin-based therapy to the FDA following previous Phase III success.
Compass Pathways posted 26-week data from its trial evaluating COMP360, showing rapid and durable benefits, while maintaining ...
Compass Pathways Plc shares fell almost 10% Tuesday after a pivotal study of its experimental psilocybin-based therapy ...
Introduction The Jeep Compass Still Trails the Best Compact SUVs Jeep’s small SUV has a peppy engine and an attractive interior, but it can’t overcome numerous flaws Overview.
The Compass is an outdated small SUV, and as such, it falls short of its competition in just about every way. A recent ...
HIGHS Attractive starting price, new engine has more power and better fuel economy, meaningful standard features. LOWS Numb steering, outclassed by its competitors, overly sensitive brake pedal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results